Bikanta is a seed startup. 1 investor tracked on Brouky Intelligence. Status: possibledead. Data sourced from Brouky Intelligence.
About
Bikanta is a biotechnology company that is developing a platform technology for targeted drug delivery. The company's technology is based on a novel class of molecules that can be engineered to bind to specific cells or tissues in the body. Once bound, these molecules can deliver drugs directly to the target site, reducing side effects and improving efficacy.
Stage
seed
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky